Application of Evidence-Based Medical Therapy Is Associated With Improved Outcomes After Percutaneous Coronary Intervention and Is a Valid Quality Indicator

This publication has 15 references indexed in Scilit:

• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome
  Circulation, 2004
• Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
  Journal of the American College of Cardiology, 2004
• Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes
  Circulation, 2004
• Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary InterventionA Randomized Controlled Trial
  JAMA, 2002
• Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction
  Circulation, 2001
• Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999
  Journal of the American College of Cardiology, 2000
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet
  The American Journal of Cardiology, 1999
• Effect of Pravastatin on Angiographic Restenosis After Coronary Balloon Angioplasty fn1fn1This study was supported by a grant from Bristol Myers Squibb Laboratories, Paris.
  Journal of the American College of Cardiology, 1997
• Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty
  New England Journal of Medicine, 1994